(GEM) Goldman Sachs ActiveBeta - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US3814302069
GEM: Emerging Markets, Equity Securities, Depositary Receipts, Underlying Stocks
The Goldman Sachs ActiveBeta Emerging Markets Equity ETF (GEM) is designed to provide investors with broad exposure to equity securities of emerging market issuers, aiming to capture the growth potential of these dynamic economies. By investing at least 80% of its assets in securities included in its underlying index, depositary receipts, and underlying stocks, the fund offers a diversified portfolio that mirrors the performance of its benchmark.
To gain a deeper understanding of GEMs investment strategy, its essential to analyze its underlying index. Although the specific index is not mentioned, its likely a widely recognized benchmark for emerging markets, such as the MSCI Emerging Markets Index. The funds focus on emerging market issuers makes it an attractive option for investors seeking to tap into the growth potential of countries like China, India, and Brazil.
Examining the
By analyzing the interplay between GEMs technical and fundamental data, we can make an informed forecast. Given the current price of $35.75, SMA20 at $35.68, and SMA50 at $34.36, we can expect the ETF to continue its upward trend, potentially reaching the 52-week high of $36.56 in the near term. However, its crucial to monitor the funds performance in relation to its underlying index and overall market conditions to adjust our forecast accordingly. A potential target price could be around $37.50, representing a 5% increase from the current price, assuming the emerging markets continue to grow and the fund maintains its diversified portfolio.
Additional Sources for GEM ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
GEM ETF Overview
Market Cap in USD | 994m |
Category | Diversified Emerging Mkts |
TER | 0.45% |
IPO / Inception | 2015-09-25 |
GEM ETF Ratings
Growth Rating | 20.3 |
Fundamental | - |
Dividend Rating | 40.7 |
Rel. Strength | 1.91 |
Analysts | - |
Fair Price Momentum | 33.90 USD |
Fair Price DCF | - |
GEM Dividends
Dividend Yield 12m | 2.35% |
Yield on Cost 5y | 3.07% |
Annual Growth 5y | 8.00% |
Payout Consistency | 82.4% |
Payout Ratio | % |
GEM Growth Ratios
Growth Correlation 3m | 92.7% |
Growth Correlation 12m | 52.8% |
Growth Correlation 5y | -9.6% |
CAGR 5y | 6.74% |
CAGR/Max DD 5y | 0.19 |
Sharpe Ratio 12m | 1.69 |
Alpha | 6.20 |
Beta | 0.664 |
Volatility | 14.86% |
Current Volume | 33.7k |
Average Volume 20d | 82.4k |
As of June 30, 2025, the stock is trading at USD 37.13 with a total of 33,735 shares traded.
Over the past week, the price has changed by +3.05%, over one month by +5.51%, over three months by +11.90% and over the past year by +16.34%.
Neither. Based on ValueRay´s Analyses, Goldman Sachs ActiveBeta is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 20.25 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of GEM is around 33.90 USD . This means that GEM is currently overvalued and has a potential downside of -8.7%.
Goldman Sachs ActiveBeta has no consensus analysts rating.
According to our own proprietary Forecast Model, GEM Goldman Sachs ActiveBeta will be worth about 38.5 in June 2026. The stock is currently trading at 37.13. This means that the stock has a potential upside of +3.61%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 38.5 | 3.6% |